TWiV 770: COVID-19 clinical update #67 with Dr. Daniel Griffin
In COVID-19 clinical update #67, Daniel Griffin reviews antibodies to the virus early in the US, serology testing of blood donations, MIS-C in children under 21, myocarditis in competitive athletes, ER visits for suspected suicide attempts, delta variant in Scotland, Novavax vaccine phase 3 results, vaccine coverage in pregnant women, early monoclonal administration reduces hospitalization and mortality, casirivimab and imdevimab recovery trial results, and CDC guidance on postacute sequelae. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! ...
Source: This Week in Virology - MP3 Edition - June 19, 2021 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Eptinezumab and Acute Migraine Treatment, COVID-19 Vaccination of Pregnant and Lactating Persons, Review of Chronic Pelvic Pain in Women, and more
(Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - June 15, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
What are the most effective interventions during pregnancy for preventing stillbirth?
The Cochrane Pregnancy and Childbirth Group has done many reviews of interventions that might prevent stillbirth and, in December 2020, they brought these together in an overview. In this podcast, one of the Group ’s researchers, Dell Horey, talks with lead author Erika Ota, a professor at the St. Luke’s International University in Japan, about the findings. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - May 27, 2021 Category: General Medicine Authors: Cochrane Source Type: podcasts
TWiV 747: COVID-19 clinical update #59 with Dr. Daniel Griffin
Daniel Griffin discusses a front-line health care worker survey, pre-exposure seropositivity and subsequent infection in healthy young adults, fitted filtration efficiency of double masking, BinaxNow rapid in-home antigen test, postvaccination infections in a nursing facility, safety of mRNA vaccine in pregnant women, case control study of Bamlanivimab, no evidence for brain infection in patients with neurolgical symptoms, and mortality among US patients hospitalized with COVID-19. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for t...
Source: This Week in Virology - MP3 Edition - April 24, 2021 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Coronapod: COVID and pregnancy - what do we know?
Since the beginning of the pandemic, there have been many open questions about how COVID-19 could impact pregnant people and their babies – confounded by a lack of data.But now, studies are finally starting to provide some answers. While it does seem that pregnancy is associated with an increased risk of hospitalisation, babies appear to be spared from severe illness in most cases.In this week’s Coronapod we talk about these findings, and the questions that remain – including whether vaccines are safe to give to pregnant people.News: Pregnancy and COVID: what the data say See acast.com/privacy for privacy and opt-out...
Source: Nature Podcast - March 12, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Coronapod: COVID and pregnancy - what do we know?
Since the beginning of the pandemic, there have been many open questions about how COVID-19 could impact pregnant people and their babies – confounded by a lack of data.But now, studies are finally starting to provide some answers. While it does seem that pregnancy is associated with an increased risk of hospitalisation, babies appear to be spared from severe illness in most cases.In this week’s Coronapod we talk about these findings, and the questions that remain – including whether vaccines are safe to give to pregnant people.News: Pregnancy and COVID: what the data say
See acast.com/privacy for privacy ...
Source: Nature Podcast - March 12, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD
Nancy E. Messonnier, MD is director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC) and leads the CDC’s efforts on COVID-19 vaccination. She joins JAMA's Q&A series to discuss the agency's response to emerging coronavirus variants, the FDA advisory hearings on the new Johnson & Johnson vaccine, and other agency activities and priorities related to COVID-19 control. Recorded February 26, 2021. Related Content: Genetic Variants of SARS-CoV-2—What Do They Mean? Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD SARS-CoV-2 V...
Source: JAMA Author Interviews - March 2, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Coronavirus Vaccination in Pregnant and Breastfeeding Individuals
As US vaccine distribution expands to include younger healthier populations, questions about vaccine safety in women of childbearing age have become more urgent. University of Texas Southwestern Medical Center's Catherine Y. Spong, MD, and Emory University School of Medicine's Denise J. Jamieson, MD, MPH, both eminent obstetrician/gynecologists, join JAMA's Q&A series to discuss the safety of the Pfizer-BioNTech and Moderna vaccines in pregnant and nursing mothers, and in individuals trying to get pregnant. Recorded February 8, 2020. Related Article(s): Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021 (Source: ...
Source: JAMA Author Interviews - February 11, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
What are the benefits and risks of giving corticosteroids to pregnant women at risk of premature birth?
One of the earliest Cochrane Reviews studied the effects of steroids for women at risk of a pre-term delivery, and built on an even earlier review. The Cochrane Review has been updated several times and the most recent version was published in December 2020. Two of the authors discuss the latest evidence in this podcast, starting with Emma McGoldrick from the Liverpool Women's NHS Foundation Trust in the UK, who ’s talking with Fiona Stewart from the Department of Women's and Children's Health at The University of Liverpool. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - January 29, 2021 Category: General Medicine Authors: Cochrane Source Type: podcasts
JAMA Psychiatry : Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects
Interview with Kayla N. Anderson, PhD, author of Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects Related Article(s): Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - December 2, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid
Listen to an audio podcast of the October 15, 2020 FDA Drug Safety Communication titled "FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. This issue affects all NSAIDs availbale by prescription and over-the-counter (OTC)." (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - October 22, 2020 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
